Literature DB >> 12810303

In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents.

Toshihiro Kushibiki1, Ryuji Tomoshige, Yasunori Fukunaka, Masawo Kakemi, Yasuhiko Tabata.   

Abstract

The objective of this paper is to investigate the in vivo release and gene expression of lacZ plasmid DNA (pSV-lacZ) by the hydrogels of cationized gelatin. Gelatin with different cationization extents was prepared by changing the amount of ethylenediamine added to aminize the carboxyl groups of gelatin with a water-soluble carbodiimide. The cationized gelatin prepared was crosslinked by various concentrations of glutaraldehyde (GA) to obtain cationized gelatin hydrogels with different cationization extents as the release carrier of plasmid DNA. When the cationized gelatin hydrogels incorporating 125I-labeled pSV-lacZ were implanted into the femoral muscle of mice, the radioactivity remaining decreased with time and the retention period was prolonged with an increase in the concentration of GA used for hydrogel preparation. In vivo experiments with 125I-labeled cationized gelatin hydrogels revealed that the higher the GA concentration, the longer the in vivo retention period of radioactivity remaining for every cationized gelatin hydrogel. Only for the hydrogels prepared from gelatin with the aminized percentages of 29.7, 41.6, and 47.8 mol.%, the time profile of pSV-lacZ retention correlated well with that of hydrogel retention. The gene expression by the cationized gelatin hydrogels incorporating pSV-lacZ depended on the aminized percentage of gelatin and was significant at the percentage of 41.6 mol.% or higher. It is possible that the pSV-lacZ was complexed with the degraded fragments of cationized gelatin and released with a positive charge, resulting in enhanced gene expression. We conclude that gelatin with a cationization extent of at least 41.6 mol.% is needed for the enhanced in vivo gene expression of plasmid DNA by the hydrogel release system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12810303     DOI: 10.1016/s0168-3659(03)00197-4

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  16 in total

Review 1.  Matrices and scaffolds for DNA delivery in tissue engineering.

Authors:  Laura De Laporte; Lonnie D Shea
Journal:  Adv Drug Deliv Rev       Date:  2007-04-14       Impact factor: 15.470

2.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

Review 3.  Biomaterial technology for tissue engineering applications.

Authors:  Yasuhiko Tabata
Journal:  J R Soc Interface       Date:  2009-03-04       Impact factor: 4.118

4.  Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin.

Authors:  Jyoti Choubey; A K Bajpai
Journal:  J Mater Sci Mater Med       Date:  2010-02-05       Impact factor: 3.896

5.  Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.

Authors:  Motoyuki Kumagai; Akira Marui; Yasuhiko Tabata; Takahide Takeda; Masaya Yamamoto; Atsushi Yonezawa; Shiro Tanaka; Shigeki Yanagi; Toshiko Ito-Ihara; Takafumi Ikeda; Toshinori Murayama; Satoshi Teramukai; Toshiya Katsura; Kazuo Matsubara; Koji Kawakami; Masayuki Yokode; Akira Shimizu; Ryuzo Sakata
Journal:  Heart Vessels       Date:  2015-04-11       Impact factor: 2.037

6.  Preparation of poly(vinyl alcohol)/DNA hydrogels via hydrogen bonds formed on ultra-high pressurization and controlled release of DNA from the hydrogels for gene delivery.

Authors:  Tsuyoshi Kimura; Sayaka Iwai; Toshiyuki Moritan; Kwangwoo Nam; Shingo Mutsuo; Hidekazu Yoshizawa; Masahiro Okada; Tsutomu Furuzono; Tosihya Fujisato; Akio Kishida
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

7.  Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

Authors:  Toshihiro Kushibiki; Kunio Matsumoto; Toshikazu Nakamura; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

8.  Effects of Tissue-Type Plasminogen Site-Specific Transgene in Gelatin-Coated Dacron on the Fibrinolysis Activity of Rabbit Left Atrium.

Authors:  Xiaobin Liu; Kailun Zhang; Xionggang Jiang; Jiahong Xia; Daokang Xiang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

9.  A therapeutic angiogenesis of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel sheets in a canine chronic myocardial infarction model.

Authors:  Motoyuki Kumagai; Kenji Minakata; Hidetoshi Masumoto; Masaya Yamamoto; Atsushi Yonezawa; Takafumi Ikeda; Kyokun Uehara; Kazuhiro Yamazaki; Tadashi Ikeda; Kazuo Matsubara; Masayuki Yokode; Akira Shimizu; Yasuhiko Tabata; Ryuzo Sakata; Kenji Minatoya
Journal:  Heart Vessels       Date:  2018-05-14       Impact factor: 2.037

10.  Controlled release of vancomycin from cross-linked gelatine.

Authors:  Domenico Tigani; Carola Zolezzi; Federico Trentani; Alessandro Ragaini; Michele Iafisco; Silvia Manara; Barbara Palazzo; Norberto Roveri
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.